APA (7th ed.) Citation

Khalafallah, A. A., Fernandopulle, B., & Brain, T. Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia. PAGEPress Publications.

Chicago Style (17th ed.) Citation

Khalafallah, Alhossain A., Bernadene Fernandopulle, and Terry Brain. Dose-modified Lenalidomide Induces Sustained Hematological Response in Patients with Intermediate to High Risk Myelodysplasia. PAGEPress Publications.

MLA (9th ed.) Citation

Khalafallah, Alhossain A., et al. Dose-modified Lenalidomide Induces Sustained Hematological Response in Patients with Intermediate to High Risk Myelodysplasia. PAGEPress Publications.